FOXO1 and Burkitt lymphoma: In GCB-DLBCL, the FOXO1 mutations are associated with poor prognosis and they are more frequent in relapsed or primary refractory cases (159, 160, 162), whereas in BL, there is no correlation with outcome or progression of the disease (161).